Studies on peptide-modified cultures demonstrate control over both tissue growth and location in vitro

“In vitro fabricated biological tissue would be a valuable tool to screen newly synthesized drugs or understand the tissue development process,” explain Takuya Matsumoto and his colleagues in a recent report. However tissues grown so far have not reached the size and final shape of natural tissue. Matsumoto and colleagues at Okayama, Osaka and Kansai Universities in Japan have now identified a tripeptide sequence that can be used to overcome both limitations. With hydrogel modified with the tripeptide they demonstrate enhanced tissue growth of a salivary gland both across a sheet of tissue and at specified localised points.

The salivary gland studied – the submandibular gland – develops a branched structure through budding and the elongation of ducts, which is also typical of other structures such as lungs, kidneys, mammary glands and spleen. Previous research revealed the importance of the glycoprotein fibronectin in the morphological development and growth of salivary gland tissue. Consequently Matsumoto and colleagues focused their investigations on the effects of the specific tripeptide sequence arginine-glycine aspartic acid (RGD) that acts as a cell binding site on fibronectin. 

The researchers studied the growth of salivary gland tissue on hydrogel both modified with different concentrations of RGD and without and found significant growth enhancements that increased with RGD concentrations. They then experimented with RGD-modified hydrogel beads and demonstrated that localised growth enhancement occurred where the beads were situated, which could provide control over morphology in artificial tissue growth. Further studies also suggested that neuronal growth and the enhancement of growth factor proteins were responsible for the enhanced gland tissue growth observed.

In their report of the work the researchers conclude, “This in vitro SMG tissue growth modulation system can have a variety of uses including tissue arrays for drug screening and as a biologic tool to understand tissue development.”


Tripeptide in previous studies

The shape development or morphogenesis of the submandibular gland develops through the formation of clefts that occur through a change in cell adhesion so that they bind to the surrounding extracellular matrix instead of each other. Previous research has shown that expression of the glycoprotein fibronectin is crucial for cleft formation. 

Integrin is a receptor protein that bridges interactions between cells and the extracellular matrix. The domain of fibronectin that binds to integrin is the tripeptide sequence arginine-glycine aspartic acid (RGD) prompting studies of this tripeptide sequence on tissue growth.

Investigations have already shown that transplanting composites containing RGD peptides onto the back of a mouse can result in the development of growth plates – the tissue at the ends of bones in growing children and adolescents. However so far there have been no studies into the growth and morphology of tissues in vitro. The ability to grow tissues in vitro is particularly important for drug screening and studies to better understand tissue growth.

The role of FGFs

Fibroblast growth factors (FGFs) are a family of proteins involved in embryonic development, wound healing and signalling pathways. Two specific FGFs play a crucial role in the growth of the two main tissue types in the submandible salivary gland – FGF7 induces budding in the epithelial tissue and FGF10 induces the elongation of ducts in the mesenchymal tissue. 

Matsumoto and colleagues imaged the salivary gland tissues grown in RGD-modified hydrogels using immunofluorescent staining and found both FGF7 and FGF10 were highly expressed. Experiments to grow the salivary gland tissues in the presence of FGF7 and FGF10 antibodies revealed that these antibodies inhibited tissue growth. The RGD-modified hydrogel was also ineffective at enhancing tissue budding in isolated epithelial cells alone.

The role of neurites

Previous studies have also suggested that neuron outgrowths – ‘neurites’ – from a region known as the parasympathetic ganglion in submandibular gland tissue are key to tissue growth. The researchers observed an even distribution of the neurite network throughout the gland tissues they had grown. Antibodies to the neurotrophic factors, which are responsible for neuron growth and survival, also inhibited submandibular gland tissue growth in RGD-modified hydrogels. 

Figure caption

a) Schematic illustration of the RGD-modified hydrogel (left) and the submandibular gland (SMG) tissue culture on hydrogel (right). b,c) SMG cultured on hydrogel sheets modified by introducing various RGD concentrations (0–0.18 mol/l), and SMG cultured on a tissue culture dish without any hydrogel substrate as a negative control (Bar = 50 μ m). A stiffer gel sheet normally attenuates SMG growth, but the SMG growth was enhanced when RGD was introduced. The SMG growth changed in accordance with the introduced amount of RGD. SMG was completely dissociated when cultured on the traditional tissue culture dish instead of hydrogel.


Hiroaki Taketa, Gulsan Ara Sathi, Mahmoud Farahat, Kazi Anisur Rahman, Takayoshi Sakai, Yoshiaki Hirano, Takuo Kuboki, Yasuhiro Torii, Takuya Matsumoto. Peptide-modified Substrate for Modulating Gland Tissue Growth and Morphology In Vitro. Scientific Reports 5, Article number: 11468 (2015).

DOI: 10.1038/srep11468

Correspondence to

Professor  Takuya Matsumoto, D.D.S., Ph.D.

Department of Biomaterials, Okayama University, 2-5-1 Shikata-Cho, Okayama, 700-8558, Japan.

E-mail: [email protected]

<Archive of Okayama University Research Updates>

Vol.1:Innovative non-invasive ‘liquid biopsy’ method to capture circulating tumor cells from blood samples for genetic testing

Vol.2:Ensuring a cool recovery from cardiac arrest

Vol.3:Organ regeneration research leaps forward

Vol.4:Cardiac mechanosensitive integrator

Vol.5:Cell injections get to the heart of congenital defects

Vol.6:Fourth key molecule identified in bone development

Vol.7:Anticancer virus solution provides an alternative to surgery

Vol.8:Light-responsive dye stimulates sight in genetically blind patients

Vol.9:Studies reveal how a diabetes drug helps towards the rejection of tumours by supporting immune cells

Vol.10:Studies reveal how high-fat low-carb diets affect brain activity and highlight an approach for treating epilepsy with metabolic drugs.

Vol.11:Compound-protein combination shows promise for arthritis treatment.

Vol.12:Molecular features of the circadian clock system in fruit flies


Further information

Okayama University

1-1-1 Tsushima-naka , Kita-ku , Okayama 700-8530, Japan

Planning and Public Information Division, Okayama University

E-mail: [email protected]


Okayama Univ. e-Bulletin:

Okayama Univ. e-Bulletin (PDF Issues):

About Okayama University (You Tube):

Okayama University Image Movie (You Tube):


About Okayama University

Okayama University is one of the largest comprehensive universities in Japan with roots going back to the Medical Education House sponsored by the Lord of Okayama and established in 1870. Now with 1,300 faculty and 14,000 students, the University offers courses in specialties ranging from medicine and pharmacy to humanities and physical sciences. Okayama University is located in the heart of Japan approximately 3 hours west of Tokyo by Shinkansen.